文献速递静脉血栓栓塞

骨科与腹部手术需延长药物血栓预防患者中梯度压力袜预防静脉血栓栓塞的有效性

The effectiveness of graduated compression stockings for prevention of venous thromboembolism in orthopedic and abdominal surgery patients requiring extended pharmacologic thromboprophylaxis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2018-08-17

该系统综述检索MEDLINE、Embase、Cochrane Library和ClinicalTrials.gov,纳入19项随机对照试验,未发现直接比较单用延长药物血栓预防与联用梯度压力袜的随机对照试验。16项随机对照试验共9824例接受延长药物血栓预防的患者中,症状性深静脉血栓发生率为0.81%(95%CI 0.5-1.20),肺栓塞为0.2%(95%CI 0.12-0.36);3项试验共337例联用梯度压力袜的患者中,症状性深静脉血栓发生率为1.61%(95%CI 0.03-5.43),未报告肺栓塞。作者认为证据不足以推荐联用梯度压力袜。

要点

  • 未发现直接比较单用延长药物血栓预防与联用梯度压力袜的随机对照试验。
  • 16项随机对照试验9824例单用延长药物血栓预防者症状性深静脉血栓0.81%、肺栓塞0.2%。
  • 3项试验337例联用梯度压力袜者症状性深静脉血栓1.61%,未报告肺栓塞。

核心结论

  • 证据不足以推荐在骨科和腹部手术患者中联用梯度压力袜与延长药物血栓预防来预防静脉血栓栓塞。
  • 需要一项直接研究该重要课题的临床试验。

研究设计与样本

  • 系统综述与随机效应Meta分析,检索MEDLINE、Embase、Cochrane Library和ClinicalTrials.gov,检索于2017年4月进行。
  • 检索遵循系统综述与Meta分析首选报告条目(PRISMA)指南,方案注册于PROSPERO(CRD42017062655)。
  • 纳入标准为随机对照试验,其中一组患者接受单用延长药物血栓预防(>21天)或联用梯度压力袜。
  • 系统检索共识别1291项研究,其中19项符合纳入标准。

主要发现

  • 未发现直接比较单用延长药物血栓预防与梯度压力袜联用延长药物血栓预防的随机对照试验。
  • 16项随机对照试验共9824例接受延长药物血栓预防的患者中,0.81%(95%CI 0.5-1.20)诊断为症状性深静脉血栓,0.2%(95%CI 0.12-0.36)发生肺栓塞。
  • 3项试验共337例接受延长药物血栓预防联用梯度压力袜的患者中,1.61%(95%CI 0.03-5.43)发生症状性深静脉血栓,未报告肺栓塞。
  • 分别分析骨科手术和腹部手术研究时观察到相似的静脉血栓栓塞发生率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未发现直接比较单用延长药物血栓预防与梯度压力袜联用延长药物血栓预防的随机对照试验。
  • 作者结论指出证据不足以推荐联用梯度压力袜,并指出需要一项直接研究该课题的临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is an increasing evidence base to support the use of extended pharmacologic thromboprophylaxis in selected surgical patients to prevent venous thromboembolism (VTE). The benefit of graduated compression stockings (GCS) in addition to extended pharmacologic thromboprophylaxis is unclear. The aim of this study was to systematically review the evidence relating to the effectiveness of using GCS in conjunction with extended pharmacologic thromboprophylaxis to prevent VTE in surgical patients. METHODS: A literature search of MEDLINE, Embase, Cochrane Library, and ClinicalTrials.gov databases was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines in April 2017. The review protocol was published on PROSPERO (CRD42017062655). Randomized controlled trials (RCTs) were eligible if one of the study arms included patients receiving extended pharmacologic thromboprophylaxis alone (>21 days) or in conjunction with GCS. Data on deep venous thrombosis (DVT), pulmonary embolism (PE), and VTE-related death were compiled. Pooled proportions of the VTE rates were determined using random-effects meta-analysis. RESULTS: The systematic search identified 1291 studies, of which 19 studies were eligible for inclusion. No RCT directly compared extended pharmacologic thromboprophylaxis alone with GCS plus extended pharmacologic thromboprophylaxis. A total of 9824 patients from 16 RCTs were treated with extended pharmacologic thromboprophylaxis, of whom 0.81% (95% confidence interval [CI], 0.5-1.20) were diagnosed with symptomatic DVT and 0.2% (95% CI, 0.12-0.36) with PE. Three trials included 337 patients who received extended pharmacologic thromboprophylaxis in conjunction with GCS. In this group, 1.61% (95% CI, 0.03-5.43) had symptomatic DVT with no reported PE. Similar VTE rates were observed when studies in orthopedic and abdominal surgery were analyzed separately. CONCLUSIONS: There is insufficient evidence to recommend GCS in conjunction with extended pharmacologic prophylaxis to prevent VTE in patients undergoing orthopedic and abdominal surgery. A clinical trial directly investigating this important subject is needed.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Milinis K, Shalhoub J, Coupland AP, et al. The effectiveness of graduated compression stockings for prevention of venous thromboembolism in orthopedic and abdominal surgery patients requiring extended pharmacologic thromboprophylaxis. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 30126797. doi:10.1016/j.jvsv.2018.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。